Agreed, but with Excellegen alone when you look at
Post# of 36519
I just can't see not looking at this in anything but in a positive light. While the vaccine is still a work in progress, Excellegen is a product that they do currently have, so that can already be marketed, AE37 has already been through one trial, so they have a one up on that already. So, this should be looked at as a big step forward.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)